scholarly journals Mass action models versus the Hill model: An analysis of tetrameric human thymidine kinase 1 positive cooperativity

2009 ◽  
Vol 4 (1) ◽  
pp. 49 ◽  
Author(s):  
Tomas Radivoyevitch
ESMO Open ◽  
2021 ◽  
Vol 6 (2) ◽  
pp. 100076
Author(s):  
A. Matikas ◽  
K. Wang ◽  
E. Lagoudaki ◽  
B. Acs ◽  
I. Zerdes ◽  
...  

2010 ◽  
Vol 19 (4) ◽  
pp. 313-318 ◽  
Author(s):  
Zhishan Li ◽  
Yinghong Wang ◽  
Jie He ◽  
Jie Ma ◽  
Liang Zhao ◽  
...  

2021 ◽  
Author(s):  
Ji Zhou ◽  
Huijun Li ◽  
Cong Fang ◽  
Junye Tan ◽  
Peng Gao ◽  
...  

Abstract Objectives. Early detection of malignant tumour is a prerequisite for a successful treatment. Here we investigate if thymidine kinase 1 is more sensitive than imaging technology to discover small invisible malignant tumours.Material and Methods. The cellular concentration of TK1 was determined by a novel automatic chemiluminescence analyzer of magnetic particle immune sandwich minimum. The primary and secondary antibodies linked to the magnetic beads were chicken anti-human thymidine kinase 1 IgY-polyclonal antibodies (IgY pAb). The minimum number of cells able to be detected by the novel detection technology using an automatic chemiluminescence analyzer were determined based on the cellar TK1 concentration of low and high TK1 cell lines of known cell count.Results. The TK1 concentration of malignant cell was found to be 0.021 pg/cell. Assuming 200 pg of total protein/cell, TK1 corresponds to 0.01 % of the total protein/cell. The concentration of TK1 in human blood serum of malignant patients is in the range of 2-10 pmol/l (pM), corresponding to about 50 x106 growing cells in the body that release TK1 into 5 litre blood. The limit visibility by imaging of a tumour is about 1 mm in diameter, corresponding to about 109cells of a cell diameter of 1µm. Conclusion. TK1 is more sensitive than imaging.


2010 ◽  
Vol 134 (3) ◽  
pp. 472-477 ◽  
Author(s):  
Sergej N. Konoplev ◽  
Herbert A. Fritsche ◽  
Susan O’Brien ◽  
William G. Wierda ◽  
Michael J. Keating ◽  
...  

2016 ◽  
Vol 6 (1) ◽  
pp. 25
Author(s):  
Heyjin Kim ◽  
Hye Jin Kang ◽  
Jin Kyung Lee ◽  
Young Jun Hong ◽  
Seok-Il Hong ◽  
...  

2018 ◽  
Vol 94 (1) ◽  
pp. 60-64 ◽  
Author(s):  
S. Okamura ◽  
T. Osaki ◽  
K. Nishimura ◽  
H. Ohsaki ◽  
M. Shintani ◽  
...  

2021 ◽  
Author(s):  
Shahan Mamoor

Gynecologic cancers including cancers of the endometrium are a clinical problem (1-4). We mined published microarray data (5, 6) to discover genes associated with endometrial cancers by comparing transcriptomes of the normal endometrium and endometrial tumors from humans. We identified thymidine kinase 1, encoded by TK1, as among the most differentially expressed genes, transcriptome-wide, in cancers of the endometrium. TK1 was expressed at significantly higher levels in endometrial tumor tissues as compared to the endometrium. Importantly, in human endometrial cancer, primary tumor expression of TK1 was correlated with recurrence-free survival in both black and white patients with low mutational burden. TK1 may be a molecule of interest in understanding the etiology or progression of human endometrial cancer.


Sign in / Sign up

Export Citation Format

Share Document